Orchestra BioMed Holdings, Inc.: Financial Report Shows Revenue Struggles

Orchestra BioMed Holdings, Inc. (OBIO)

Company Profile:

• Orchestra BioMed Holdings, Inc. is a biomedical innovation company in the healthcare sector.
• The company is based in New Hope, Pennsylvania and operates in the biotechnology industry.
• Its flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension, and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease.
• Orchestra BioMed Holdings also develops FreeHold devices and minimally invasive surgery devices.
• The company has strategic collaborations with Medtronic and Terumo Corporation for the development and commercialization of its products.
• The leadership team includes Mr. David P. Hochman (Founder, Chairman of the Board of Directors & CEO) and Mr. Darren R. Sherman (Founder, President, COO & Director).

Financial Summary:

• The previous close of Orchestra BioMed Holdings, Inc. stock was $5.00 per share.
• The stock opened at $5.67 and has a bid price of $5.15 (100 shares) and an ask price of $5.44 (100 shares).
• The day's range of the stock is $5.11 to $5.67, and the 52-week range is $4.26 to $23.39.
• The volume of the stock is currently at 43,189 shares, with an average volume of 53,716 shares.
• The market capitalization of Orchestra BioMed Holdings, Inc. is $188.013 million.
• The beta (5Y monthly) of the stock is 0.18.

Financial Analysis:

• The trailing twelve months (TTM) price-to-earnings (P/E) ratio of Orchestra BioMed Holdings, Inc. is not available.
• The TTM earnings per share (EPS) of the company is -$0.91.
• The estimated one-year target price for the stock is $16.33.

Historical Stock Data:

• The historical stock data of Orchestra BioMed Holdings, Inc. shows that the stock has experienced fluctuations in its price over the past year.
• The stock has a 52-week low of $4.26 and a 52-week high of $23.39.

Dividend Information:

• Orchestra BioMed Holdings, Inc. does not currently pay dividends.

Note: The information provided is based on the latest available data for Orchestra BioMed Holdings, Inc. and is subject to change.